Recent CSO figures show Ireland's exports, especially in medical and pharmaceutical products, have surged, marking €99.9 billion in sales. However, with 2024 projections highlighting the US as a crucial growth market amid President Trump’s tariff threats, concerns are raised. Irish imports from the US saw a slight decrease, emphasizing an imbalance. Experts urge Irish companies to conduct risk assessments and strategize to mitigate impacts from ongoing trade tensions, particularly as the US remains a pivotal market for Irish goods.
"While these are very encouraging for Ireland, the manner in which the US is both our largest export market outside the EU and our fastest-growing market in 2024 remains a key concern."
"Amid the ongoing trade wars and retaliatory tariffs being proposed by the US, Irish companies should ensure they have prioritised carrying out a risk assessment on their US sales..."
Collection
[
|
...
]